儿童唐氏综合征上气道刺激:患者选择与植入后优化
美国食品药品监督管理局近期批准上气道刺激(UAS)用于符合特定纳入和排除标准的唐氏综合征合并持续阻塞性睡眠呼吸暂停的儿童。本文通过专家小组采用改良德尔菲法形成儿童唐氏综合征UAS患者选择和植入后优化最佳实践算法,30条陈述中29条达成共识,1条未达成共识。
要点
- 专家小组就儿童唐氏综合征UAS患者选择和植入后优化形成29条共识陈述。
- 标准化方案需考虑唐氏综合征儿童感觉处理障碍高发等独特挑战。
- 共识陈述涵盖药物诱导睡眠内镜检查、预激活阈值测量、设备滴定和随访睡眠研究。
核心结论
- 针对唐氏综合征儿童的UAS标准化方案必须考虑治疗感觉处理障碍高发的复杂儿科人群所固有的独特挑战。
- 该专家小组已就若干陈述达成共识,将在采用这一新型疗法时指导临床医生。
研究设计与样本
- 专家小组制定最佳实践算法。
- 多机构研究者综述。
- 专家小组由在儿童唐氏综合征舌下神经刺激方面具有丰富经验的儿童耳鼻咽喉科医生组成。
- 在初始起草会议上创建了30条陈述。
- 采用改良德尔菲法评估专家小组的共识。
主要发现
- 经过2轮德尔菲调查,29条陈述符合共识标准。
- 1条陈述未达成共识。
- 陈述被分组为若干类别以便于呈现。
关键数值与推荐
- 美国食品药品监督管理局近期批准上气道刺激(UAS)用于符合特定纳入和排除标准的唐氏综合征合并持续阻塞性睡眠呼吸暂停的儿童。
- 本综述旨在整合若干机构的患者选择和植入后优化方案,包括儿童唐氏综合征药物诱导睡眠内镜检查方案、预激活阈值测量、设备滴定和随访睡眠研究。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Food and Drug Administration recently approved upper airway stimulation (UAS) for children with Down Syndrome and persistent obstructive sleep apnea who meet certain inclusion and exclusion criteria. Although there is a robust experience with this therapy in the adult population, established protocols used in adults are not directly transferrable to a complex pediatric population. This review aims to combine the protocols from several institutions for patient selection and postimplantation optimization, including a protocol for Drug-Induced Sleep Endoscopy in children with Down Syndrome, preactivation threshold measurements, device titration, and follow-up sleep studies. STUDY DESIGN: Expert panel development of best Practice algorithm. SETTING: Multi-institutional investigator review. METHODS: An expert panel was assembled of pediatric otolaryngologists with extensive experience in hypoglossal nerve stimulation in children with Down Syndrome. Thirty statements were created during an initial drafting session. A modified Delphi method was used assess consensus among the panel. RESULTS: After 2 rounds of Delphi surveys, 29 statements met criteria for consensus. One statement did not meet consensus. The statements were grouped into several categories to facilitate presentation. CONCLUSIONS: A standardized approach to UAS for children with Down Syndrome must take into account the unique challenges inherent to treating a complex pediatric population with a high rate of sensory processing disorders. This expert panel has met consensus on several statements that will guide clinicians as this novel therapy is adopted.
引用
- Chieffe D, Baldassari CM, Friedman N, et al. Pediatric Down Syndrome Upper Airway Stimulation: Patient Selection and Post-Implantation Optimization. Otolaryngol Head Neck Surg. 2024. PMID: 38169046. doi:10.1002/ohn.633
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。